ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
78.71
-0.04
(-0.05%)
Cerrado 22 Enero 3:00PM
78.71
0.00
(0.00%)
Fuera de horario: 4:30PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
78.71
Postura de Compra
77.00
Postura de Venta
79.95
Volume Operado de la Acción
1,144,598
77.60 Rango del Día 79.14
61.16 Rango de 52 semanas 85.57
Capitalización de Mercado [m]
Precio Anterior
78.75
Precio de Apertura
78.19
Última hora de negociación
Volumen financiero
US$ 89,872,916
Precio Promedio Ponderado
78.5192
Volumen promedio (3 m)
903,963
Acciones en circulación
158,891,800
Rendimiento del Dividendo
0.41%
Ratio Precio/Utilidad
74.40
Beneficio por acción (BPA)
1.06
turnover
1.16B
Beneficio neto
168.11M

Acerca de Bio Techne Corporation

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Mostrar más

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
Sede
Minneapolis, Minnesota, USA
Fundado
-
Bio Techne Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TECH. The last closing price for Bio Techne was US$78.75. Over the last year, Bio Techne shares have traded in a share price range of US$ 61.16 to US$ 85.57.

Bio Techne currently has 158,891,800 shares in issue. The market capitalisation of Bio Techne is US$12.51 billion. Bio Techne has a price to earnings ratio (PE ratio) of 74.40.

TECH Últimas noticias

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio PR Newswire ST. PAUL, Minn., Jan. 21, 2025 ST. PAUL, Minn., Jan. 21, 2025 /PRNewswire/ -- ScaleReady, in collaboration with...

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire MINNEAPOLIS, Jan. 10, 2025 MINNEAPOLIS, Jan. 10, 2025...

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire ST. PAUL, Minn., Jan. 8, 2025 ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in...

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire MINNEAPOLIS, Jan. 7, 2025 MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...

ScaleReady awards a G-Rex® Grant to Moonlight Bio

ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
12.573.3753611767876.1479.773.6791268176.47284228CS
46.38.7004557381672.4179.770.75574570774.81099388CS
124.716.364864864867480.865.6190396373.61906541CS
262.363.0910281597976.3583.6265.6189394674.19915377CS
527.7710.952917958870.9485.5761.1696932573.39281185CS
156-12.51-13.714097785691.22113.80551.7978298275.8145937CS
26023.137541.634801385655.5725135.962538.792555738278.05681528CS

TECH - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Bio Techne?
El precio actual de las acciones de Bio Techne es US$ 78.71
¿Cuántas acciones de Bio Techne están en circulación?
Bio Techne tiene 158,891,800 acciones en circulación
¿Cuál es la capitalización de mercado de Bio Techne?
La capitalización de mercado de Bio Techne es USD 12.51B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Bio Techne?
Bio Techne ha negociado en un rango de US$ 61.16 a US$ 85.57 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Bio Techne?
El ratio precio/beneficio de Bio Techne es 74.4
¿Cuál es el ratio de efectivo a ventas de Bio Techne?
El ratio de efectivo a ventas de Bio Techne es 10.79
¿Cuál es la moneda de reporte de Bio Techne?
Bio Techne presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Bio Techne?
El último ingresos anual de Bio Techne es USD 1.16B
¿Cuál es el último beneficio anual de Bio Techne?
El último beneficio anual de Bio Techne es USD 168.11M
¿Cuál es la dirección registrada de Bio Techne?
La dirección registrada de Bio Techne es 614 MCKINLEY PLACE N.E, MINNEAPOLIS, MINNESOTA, 55413
¿Cuál es la dirección del sitio web de Bio Techne?
La dirección del sitio web de Bio Techne es www.bio-techne.com
¿En qué sector industrial opera Bio Techne?
Bio Techne opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BLBXBlackBoxStocks Inc
US$ 5.53
(227.22%)
229.08M
ASSTAsset Entities Inc
US$ 1.36
(51.11%)
121.68M
STAIScanTech AI Systems Inc
US$ 2.12
(44.22%)
51.68M
JYDJayud Global Logistics Ltd
US$ 3.53
(42.91%)
1.27M
NTRBNutriband Inc
US$ 7.39
(41.84%)
3.88M
STFSStar Fashion Culture Holdings Ltd
US$ 2.62
(-80.61%)
30.25M
HEPAHepion Pharmaceuticals Inc
US$ 0.135
(-58.05%)
39.89M
STBXStarBox Group Holdings Ltd
US$ 0.6201
(-36.50%)
1.63M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 93.51
(-35.73%)
1
JUNSJupiter Neurosciences Inc
US$ 3.61
(-33.39%)
6.87M
IPAImmunoPrecise Antibodies Ltd
US$ 0.6446
(30.75%)
296.43M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3191
(33.57%)
229.11M
BLBXBlackBoxStocks Inc
US$ 5.53
(227.22%)
229.08M
NVDANVIDIA Corporation
US$ 147.07
(4.43%)
216.62M
RGTIRigetti Computing Inc
US$ 13.89
(-0.64%)
154.54M

TECH Discussion

Ver más
Monksdream Monksdream 3 meses hace
TECH under $75
👍️0
Monksdream Monksdream 4 meses hace
TECH range bound
👍️0
Monksdream Monksdream 6 meses hace
TECH under $100
👍️0
LordTurkeyBaster LordTurkeyBaster 3 años hace
Top Meme Stock Mentions Money to Move 01/03/2022

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 años hace
Top Meme Stock Mentions Money to Move 10/15/2021

$TECH: $2B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
LordTurkeyBaster LordTurkeyBaster 3 años hace
Top Meme Stock Mentions Money to Move 10/14/2021

$TECH: $1B

Money to Move is a proprietary estimate of the total added monetary volume required to move a stock based on float liquidity and short percentage. Updated daily for high social interest stocks.

See more... https://gravityanalyticaresearch.com https://gravityanalytica.com
👍️0
TREND1 TREND1 10 años hace
NO REASON.
👍️0
getarealjob getarealjob 10 años hace
No worries, just read a blurb on a new diet drug that sounds pretty promising from these guys. Fexaramine, from these guys, looking at clinicals in 2-3 years.

Is there a reason you're no longer following it or just got tired and needed more time with others?
👍️0
TREND1 TREND1 10 años hace
NO longer follow TECH.
SORRY
👍️0
getarealjob getarealjob 10 años hace
Hey Trend, saw you over on AAL. This guy just popped up on my radar, obviously nothing going on in the board. What are your thoughts on this, if you have any beyond your charts? Not sure if you're on this one or not.
👍️0
TREND1 TREND1 10 años hace
TECH D
👍️0

Su Consulta Reciente

Delayed Upgrade Clock